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Summary
Nucleotide excision repair (NER) is a highly conserved
genome repair pathway acting on helix distorting DNA
lesions. NER is divided into two subpathways: global
genome NER (GG-NER), which is responsible for
repair throughout genomes, and transcription-
coupled NER (TC-NER), which acts on lesions that
impede transcription. The extent of the Trypanosoma
brucei genome that is transcribed is highly unusual,
since most genes are organized in multigene tran-
scription units, each transcribed from a single pro-
moter. Given this transcription organization, we have
addressed the importance of NER to T. brucei genome
maintenance by performing RNAi against all predicted
contributing factors. Our results indicate that TC-NER
is the main pathway of NER repair, but only CSB, XPBz
and XPG contribute. Moreover, we show that UV
lesions are inefficiently repaired in T. brucei, perhaps
due to preferential use of RNA polymerase translesion
synthesis. RNAi of XPC and DDB was found to be
lethal, and we show that these factors act in inter-
strand cross-link repair. XPD and XPB appear only to
act in transcription, not repair. This work indicates
that the predominance of multigenic transcription in
T. brucei has resulted in pronounced adaptation of
NER relative to the host and may be an attractive drug
target.
Introduction
DNA genomes are exposed to a myriad of agents that
modify or alter their structures. Some of these agents, like
reactive oxygen species and reactive nitrogen species,
can be produced endogenously, while others, such as
ionizing radiation, UV light and harmful chemicals, are
derived from the environment. To maintain genomic stabil-
ity most living organisms possess multiple pathways to
repair such DNA damage. Nucleotide excision repair
(NER) is responsible for removing a remarkable variety of
DNA lesions, including bulky adducts covalently attached
to DNA and other forms of damage that distort the double
helix structure (Naegeli and Sugasawa, 2011). NER
defects in humans are associated with the cancer-prone
syndrome xeroderma pigmentosum (XP) and with the
developmental disorders Cockayne syndrome and trico-
thiodistrophy (Lehmann, 2001; Vermeulen et al., 2001;
Emmert et al., 2009; Cameroni et al., 2010). NER is com-
posed of two subpathways: Global Genome Nucleotide
Excision Repair (GG-NER), which recognizes lesions
genome-wide, and Transcription-Coupled NER (TC-NER),
which recognizes DNA lesions that block elongation of
RNA polymerase (Pol) in the transcribed strand of active
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genes (Naegeli and Sugasawa, 2011). It is widely consid-
ered that GG-NER and TC-NER operate together in all
organisms to maintain genome fidelity. In this study we
have asked whether or not such parallel functioning of the
two NER pathways is maintained in trypanosomatids,
eukaryotes in which gene expression is highly diverged.
During GG-NER in humans XPC (XP factor C), together
with RAD23b and Centrin-2 (Mu et al., 1995; Araujo et al.,
2000; Araki et al., 2001; Nishi et al., 2005), recognizes
local strand openings associated with double strand helix-
distorting lesions (Min and Pavletich, 2007). In some
cases, XPC recruitment can be aided by a dimer of the
UV-damaged DNA binding (UV-DDB) protein, composed
of DDB1 and XPE (DDB2) subunits, the latter of which
recognizes UV-induced lesions in the context of chromatin
(Feldberg and Grossman, 1976; Chu and Chang, 1988).
The damage is then handed off to XPC, which promotes
loading of the TFIIH transcription factor complex through
the NER protein’s C-terminal domain. TFIIH is composed
of 10 proteins, divided into two subcomplexes: the core,
which contains two helicases, XPB and XPD, and five
associated proteins (p62, p52, p44, p34 and p8/TTD-A);
and CAK, the kinase activating complex (Compe and
Egly, 2012). TFIIH is recruited by XPC interaction with
XPB and with p62, allowing damage excision to begin by
opening the DNA helix around the lesion. The XPB and
XPD helicases act in this reaction, though it appears that
XPD helicase activity is crucial, while XPB provides
ATPase, but not helicase, activity (Oksenych and Coin,
2009). Once DNA denaturation is established, RPA is
loaded to protect the single-stranded DNA in the bubble.
At the same time XPA is also loaded in order to stabilize
the TFIIH-XPC complex, as well as to cause release of the
CAK subcomplex, which coincides with recruitment of the
NER incision endonucleases, XPF/ERCC1 and XPG.
XPF/ERCC1 catalyses incision 5′ of the lesion, while XPG
executes an incision 3′. This leads to excision of a DNA
oligonucleotide containing the lesion, though the 3′ inci-
sion appears to occur after Replication Factor C and
Proliferating Cell Nuclear Antigen are recruited and
co-ordinate loading of the replication machinery needed
for repair, composed of DNA Pols delta and kappa in
non-dividing cells, and DNA Pol epsilon in replicative cells
(Ogi et al., 2010). Following gap-filling, the remaining nick
is sealed by DNA ligase I or DNA ligase III in dividing and
non-dividing cells respectively (Fagbemi et al., 2011).
TC-NER differs from GG-NER in the DNA damage rec-
ognition step, which is made through identification of
stalled RNA Pol at lesions in transcribed genes. RNA Pol
II (and perhaps also RNA Pol I) blockage increases inter-
action of the polymerase with the Cockayne syndrome
type B (CSB) protein, an SNF2 ATPase, which may stimu-
late RNA Pol translocation along the DNA strand, allowing
TFIIH complex access to the lesion site (Hanawalt and
Spivak, 2008). From then, the TC-NER and GG-NER
pathways proceed in the same way. In TC-NER ongoing
transcription can be aborted if RNA Pol disengages with
the template, or may resume if the enzyme complex
remains attached, which may require the action of CSA in
eukaryotes, perhaps by antagonizing CSB (Hanawalt and
Spivak, 2008). XPG has also been shown to interact with
CSB and RNA Pol II, and may be responsible for allowing
NER to occur without release of RNA Pol (Sarker et al.,
2005). NER may not occur in all cases, however. In some
circumstances, RNA Pol can insert nucleotides opposite
lesions, including UV damage (Walmacq et al., 2012), and
extend beyond the blockage in an error-prone fashion, a
process termed transcriptional mutagenesis (Saxowsky
and Doetsch, 2006; Bregeon and Doetsch, 2011). Though
such translesion transcription through damaged DNA tem-
plates can lead to mutant transcripts, this process rescues
cells from death by severe stalling of RNA Pol, a strong
signal for apoptosis.
Trypanosomatids are flagellated protists, which may
have emerged early during eukaryotic evolution and
display several highly diverged biological processes.
Trypanosoma cruzi, Trypanosoma brucei and Leishmania
sp are among the most studied organisms of this family and
are sources, respectively, of Chagas disease in Latin
America, sleeping sickness in sub-Saharan Africa and
leishmaniasis in tropical areas, collectively affecting more
than 20 million people (http://www.who.int/topics/en/, last
accessed 2012). To date, only a few studies have exam-
ined NER in these organisms. The machinery is largely
conserved (see Results), though genome sequencing
failed to reveal orthologues of the smaller subunit of the
UV-DDB dimer (DDB2), XPAor CSA(Berriman et al., 2005;
El-Sayed et al., 2005; Ivens et al., 2005), and two distinct
XPB-like proteins were identified, designated TbXPB and
TbXPBz (Lecordier et al., 2007; Badjatia et al., 2013).
Furthermore, trypanosomatid TFIIH lacks the CAK
complex and associates with two trypanosomatid-specific
proteins, TSP1 and TSP2 (Lee et al., 2009). The implica-
tions for NER of these changes are unknown; for instance,
CAK disassociation from TFIIH is considered a critical step
for recruitment of XPF/ERCC1 and XPG to the lesion site
during NER (Svejstrup et al., 1995; Coin et al., 2008). More
broadly, the genomes of trypanosomatids provide a unique
eukaryotic landscape in which NER must operate. Here,
the vast majority of protein-coding genes are found in
directional gene clusters, each of which is transcribed from
a single promoter, generating primary transcripts from
which individual mRNAs are derived by trans-splicing
(Daniels et al., 2010). Thus, trypanosomatid chromo-
somes contain few promoters (Siegel et al., 2009), which
may be constitutively active, meaning that the extent of the
genome that is transcribed and the uniform level of this
transcription is unprecedented in eukaryotes, where one
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gene/one promoter and variable gene transcription rates
are considered the norm. The consequences of this
genetic organization for trypanosomatid genome stability
have been little explored. For instance, collisions between
the DNA replisome and RNA Pol at genes transcribed
during S phase are associated with genomic instability,
which is limited by the evolution of replication and tran-
scription co-directionality in some highly expressed genes
in bacteria and humans (Kim and Jinks-Robertson, 2012).
Remarkably, replication origin mapping in T. brucei has
shown that multigenic transcription units can meet replica-
tion forks head-on and slow their progress, despite the
prediction that such collisions would have a pronounced
cost in this genome (Tiengwe et al., 2012).
In this study, we have examined how trypanosomatid
gene organization influences NER. A priori, it might be
predicted that the transit of RNA Pol through promoter-
distal genes of a multigene transcription unit encounters a
greater number of lesions than promoter-proximal genes.
Indeed, UV treatment provided the first evidence for mul-
tigene transcription in T. brucei, causing greater impedi-
ment to the transcription in cell extracts of a Variant Surface
Glycoprotein (VSG) gene ∼ 60 kbp from its RNA Pol I
promoter than Expression Site Associated Genes found
within the same transcription unit but closer to the promoter
(Johnson et al., 1987; Coquelet et al., 1989). The same
differential UV effect is seen for genes residing in RNA Pol
II multigene transcription units (Martinez-Calvillo et al.,
2003; 2004). Despite these observations, there is no evi-
dence that mRNA levels show a simple inverse correlation
with distance of genes from the promoter (Poon et al.,
2012). If, and how, NER in these parasites might contribute
to the maintenance of gene expression and function in the
context of multigenic transcription has not been examined.
To investigate this question, we have performed RNAi
against all putative annotated NER factors in bloodstream
form (BSF; mammal-derived) T. brucei, both in the
absence and presence of genotoxic agents, and have
analysed relative survival and mRNA abundance across
an RNA Pol II polycistron. We have also evaluated DNA
repair kinetics in T. brucei and T. cruzi cells exposed to UV
irradiation and cisplatin. We show that TbXPC, TbDDB,
TbXPB and TbXPD are essential in T. brucei, but we find
no evidence that these factors act in NER. Our data show
that TC-NER is the major NER pathway in this organism,
though only TbCSB, TbXPG and TbXPBz act in this reac-
tion, at least among the genes examined. In addition, we
suggest that translesion RNA synthesis is favoured over
repair and this pathway selection is mediated by CSB.
Taken together, these results suggest that genome predic-
tions of parallel functioning of TC-NER and GG-NER are
incorrect and instead there is pronounced separation of
NER pathways in T. brucei, an evolutionary adaptation that
is associated with specialization of the NER machinery.
Results
Growth of bloodstream form T. brucei following RNAi
knockdown of putative NER components
Genome sequencing of T. brucei revealed the presence of
most NER factors, suggesting that GG-NER and TC-NER
pathways are present in this parasite and in T. cruzi and
L. major (Berriman et al., 2005; El-Sayed et al., 2005;
Ivens et al., 2005). Sequence comparisons of the pre-
dicted T. brucei NER proteins relative to their counterparts
found in other organisms were performed (Figs S1–S9),
and gene IDs are provided in Table 1. Among GG-NER
factors, a T. brucei orthologue of XPC (TbXPC) and its
binding partner RAD23 were clearly conserved, and a
putative orthologue of the larger of the UV-DDB dimer
subunits showed weak homology to DDB1 proteins from
Homo sapiens and Arabidopsis thaliana. The smaller
DDB2 subunit could not be found in T. brucei and for
simplicity we refer to the conserved T. brucei subunit as
TbDDB. For TC-NER, a CSB orthologue was readily iden-
Table 1. Putative NER factors in T. brucei (including gene ID from http://tritrypdb.org), and the phenotypes detected after RNAi.
Factor name Gene ID
Growth
impairment?
UV
sensitive?
Cisplatin
sensitive?
Cyclophosphamide
sensitive?
TbXPC Tb927.9.11930 + − − +
TbRAD23 Tb927.6.4650 N/D N/D N/D N/D
TbDDB Tb927.6.5110 + − − +
TbCSB Tb927.7.4080 (−) + + −
TbXPBz Tb927.11.16270 − + + −
TbXPB Tb927.3.5100 + − − −
TbXPD Tb927.8.5980 + − − −
TbXPG Tb927.9.11760 − − + −
TbERCC1 Tb927.7.2060 N/D N/D N/D N/D
TbXPF Tb927.5.3670 N/D N/D N/D N/D
‘+’ indicates effect; ‘−’ indicates no effect; ‘(−)’ indicates weak effect; and ‘N/D’ indicates not determined.
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tified, but no clear CSA-encoding gene. Sequence analy-
sis of TbXPB, TbXPBz and TbXPD made previously
(Lecordier et al., 2007; Badjatia et al., 2013) was con-
firmed (data not shown). The presence of two XPB-like
proteins is not unique to trypanosomatids, but is also seen
in plants (Morgante et al., 2005) and in most crenarchaea
(Richards et al., 2008). However, the trypanosomatid pro-
teins, like those in the archaea, display considerable
sequence and size divergence, whereas the two plant
XPBs are very closely related paralogues (Fig. S6). Thus,
functional divergence of the two XPB factors is more likely
in trypanosomatids and in archaea than in plants. Finally,
the predicted NER endonucleases could be identified.
TbXPG is substantially smaller (746 amino acid residues)
than H. sapiens and A. thaliana orthologues (both greater
than 1100 amino acids; Fig. S7), due to the absence of
residues in the parasite protein within the human XPG
‘spacer’ region that is important in TFIIH interaction and
separates conserved N- and I-region nuclease domains
(Dunand-Sauthier et al., 2005). Putative orthologues of
both subunits of the XPF/ERCC1 complex could be iden-
tified, though TbXPF was more clearly conserved than
TbERCC1.
Constructs for the generation of stem-loop RNAs against
all the above ORFs except TbRAD23 were produced
and introduced into BSF T. brucei cells that allow the
tetracycline-controlled induction of RNAi (Alsford and
Horn, 2008; Jones et al., 2014). To test for the induction of
RNAi, mRNA levels of each target NER gene from the
respective cell line were measured by quantitative RT-PCR
in the presence and absence of tetracycline; significant
loss of mRNA was detectable for most genes 24–48 h
post RNAi induction (Fig. 1). However, RNAi of TbXPF or
TbERCC1, though resulting in pronounced cell growth and
DNA damage response phenotypes, unexpectedly caused
increased, not decreased, levels of mRNA, a response that
we cannot yet explain (data not shown). For this reason,
the effects of RNAi on these two putative NER genes are
not detailed here. Cell growth was measured to determine
the effect of the RNAi inductions (Fig. 1), which revealed
that TbXPC, TbDDB, TbXPB and TbXPD are essential in
this life cycle stage, since pronounced growth impairment
was seen following RNAi of each gene product (Fig. 1A, B,
D and F). In all cases, growth reduction was seen 24–48 h
post RNAi induction, and this was followed in 24–48 h by
cell death. The growth profile we observed following RNAi
of TbXPB and TbXPD closely matched that described
previously (Lecordier et al., 2007). In contrast, RNAi of
further putative T. brucei NER components had much less
impact. RNAi of TbCSB resulted in a slightly reduced
growth rate compared with non-induced controls, though
this was only detectable beyond 4 days after RNAi induc-
tion (Fig. 1C and data not shown). RNAi against TbXPBz
and TbXPG had no discernible effect on cell growth
(Fig. 1E and G), even up to 7 days post induction (data not
shown); for TbXPBz, this finding is consistent with obser-
vations by Badjatia et al. (2013).
TbCSB and TbXPBz are involved in DNA damage
recovery after UV irradiation
Ultraviolet radiation causes cyclobutane pyrimidine
dimers (CPDs) and 6-4 photoproduct (6-4 PP) lesions in
DNA, which can be repaired either by direct repair in
organisms endowed with photolyase (Beukers et al.,
2008) or by NER. To determine the role of the putative
T. brucei NER genes in DNA damage recovery after UV
irradiation, growth of the RNAi cells was measured after
treatment with UVC. To do this, 24 h after the addition of
tetracycline to induce RNAi, the cells were exposed to 0,
500, 1500 or 3000 J m−2 UVC and cell density measured
24 h later; control cells in which RNAi was not induced
were treated in the same way. Survival of the cells was
determined by calculating the cell density of the RNAi-
induced or uninduced cells at the different levels of UVC
relative to untreated cells (Fig. 2). TbCSB and TbXPBz
were found to play an important function in T. brucei sur-
vival after UV exposure, since RNAi against these two
factors resulted in a pronounced increase in cell death
relative to non-RNAi induced controls. In contrast, RNAi of
TbXPG led to somewhat increased survival, suggesting
that the endonuclease antagonizes UV damage process-
ing, at least in these conditions. Finally, RNAi of TbXPC,
TbDDB, TbXPB or TbXPD had no effect on survival after
UV irradiation, suggesting that UV lesions in T. brucei are
not recognized by the putative GG-NER proteins TbXPC
and TbDDB, and nor are they acted upon by the parasite
TFIIH-associated helicases.
UV-induced lesions are not always repaired
in trypanosomatids
The above observations could be explained by UV-
induced lesions being repaired predominantly by
TC-NER, mediated by TbCSB and TbXPBz. Alternatively,
UV damage may in some circumstances be bypassed,
such as by translesion RNA synthesis, a hitherto unseen
pathway in trypanosomatids. In order to address this, the
kinetics of UV-induced DNA damage repair were analysed
using a quantitative, PCR-based technique (Santos et al.,
2006). Cells were treated with 1500 J m−2 of UV radiation
and lesion density within a ∼ 10 kbp region of transcribed
nuclear DNA measured at a number of time points after
exposure. At this level of UV exposure, ∼ 1.5 PCR-
blocking lesions were found in the 10 kbp locus tested,
and repair was remarkably slow, since there was no clear
reduction in lesion density for up to 10 h post treatment
(Fig. 3A). The DNA repair kinetic analysis was performed
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only within this time frame as it corresponds with the
approximate doubling time of BSF T. brucei cells, thus
minimizing the effect of newly synthesized DNA, which
would dilute the damaged templates. To address if DNA
damage caused by UV radiation persists beyond a single
cell cycle, antiserum against CPDs and 6-4 PPs were
used to detect these lesions by immunofluorescence, and
signal was readily detected 24 h after UV treatment
(Fig. 3B). To determine if these slow repair kinetics are
limited to T. brucei, the PCR assay was performed in
epimastigote T. cruzi cells. PCR-blocking lesions accumu-
lated to a very similar extent, and there was little evidence
for repair of the UV-induced lesions for up to 24 h post
treatment (Fig. 3C).
TbCSB, TbXPBz and TbXPG participate in TC-NER of
lesions induced by cisplatin
Cisplatin has been used for over 30 years in the treatment
of many types of cancer (Stordal and Davey, 2007). It
Fig. 1. Growth curves of T. brucei cells following RNAi of NER factors. Growth curves are shown of T. brucei bloodstream form cells in the
absence (solid lines) or presence (dotted lines) of tetracycline induction of RNAi against the putative NER factors TbXPC, TbDDB, TbCSB,
TbXPB, TbXPBz, TbXPD and TbXPG (A–G respectively). Cell concentrations were multiplied by dilutions made during growth to obtain the
cumulative amount of parasites during the time-course. Data points are the mean of three experiments, each performed in triplicate, and
vertical lines denote standard deviation. In each growth curve, the insert shows qRT-PCR quantification of the levels of mRNA for the
RNAi-targeted gene 24 (white box) or 48 h (hatched) after induction of RNAi, relative to mRNA levels before induction (black); vertical lines
denote standard deviation from three experiments and *, ** and *** indicate P-values of < 0.05, < 0.01 and < 0.001 respectively.
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Fig. 2. TbCSB and TbXPBz are involved in DNA damage recovery after UV irradiation. Survival curves of T. brucei bloodstream form cells
after treatment with 500, 1500 or 3000 J m−2 of UVC in the absence (solid lines) or presence (dotted lines) of tetracycline induction of RNAi
against NER factors TbXPC, TbDDB, TbCSB, TbXPB, TbXPBz, TbXPD and TbXPD (A–G respectively). Percent survival was calculated as
the relative number of cells in the treated groups compared with untreated controls. Values are the means of three experiments, and vertical
lines denote standard deviation.
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induces predominantly intrastrand cross-links between
adenine and guanine residues and between adjacent
guanines; a minor proportion of cisplatin damage is inter-
strand cross-links (Masters and Koberle, 2003). Cisplatin-
induced intrastrand cross-links are mainly repaired by
NER. To investigate the role of NER in responding to
cisplatin in T. brucei, the BSF RNAi cell lines were culti-
vated in the presence of 0, 1, 2 or 5 μM cisplatin, with and
without RNAi induction, and survival measured as before
(Fig. 4). RNAi knockdown of TbCSB or TbXPBz resulted
in increased sensitivity to cisplatin, similar to that seen for
UV. In addition, RNAi of TbXPG, which did not appear to
act in the response to UV, also rendered the parasites
sensitive to cisplatin. These data indicate that TC-NER
facilitates repair of cisplatin DNA damage, recruiting the
XPG endonuclease for this purpose. In contrast, RNAi
against TbXPC, TbDDB or TbXPB resulted in increased
tolerance to cisplatin, perhaps suggesting that these puta-
tive GG-NER factors can recognize adducts induced by
cisplatin, but this does not direct the lesions to repair.
RNAi of TbXPD did not affect cisplatin sensitivity.
Lesions generated by cisplatin are removed from
trypanosomatid DNA with high efficiency by TC-NER
To determine the efficiency of removal of lesions generated
by cisplatin, the kinetics of DNA repair were measured by
the quantitative PCR assay after T. brucei BSF cells had
been exposed to 100 μM cisplatin for one hour. In these
conditions ∼ 1.5 lesions were formed in the 10 kbp region
analysed and DNA repair was highly efficient, since virtu-
ally all lesions were removed after one hour (Fig. 5A). The
DNA repair efficiency was also measured in epimastigote
T. cruzi cells, revealing the same rapid repair (Fig. 5B).
These data indicate that DNA injury caused by cisplatin is
processed differently from UV. To test if the removal of
cisplatin is mediated by TC-NER, we performed immuno-
fluorescence with antiserum against cisplatin (Fig. 5C and
D). TbCSB RNAi cells were exposed to 50 μM cisplatin for
one hour, with or without prior induction of RNAi for 24 h,
and the cells were visualized at this time point and at one
and 24 h subsequently. With or without RNAi, cisplatin
damage was detectable in the nucleus of the cells imme-
Fig. 3. UV-induced lesions are not always repaired in T. brucei.
A. Number of lesions per 10 kb in the nucleus of bloodstream form T. brucei versus time in hours, after 1500 J m−2 of UVC irradiation. The
concentration of DNA lesions was measured up to 10 h after DNA damage induction. Each value is the mean of two biological replicates, and
were derived from relative quantitative PCR-amplification values obtained from two independent measurements.
B. Immunofluorescence microscopy of 6-4 photoproducts (6-4 PP; upper) and cyclobutane pyrimidine dimers (CPD; lower) in bloodstream
form T. brucei after treatment with 1500 J m−2 of UVC. The scale bar represents a length of 10 μM.
C. Number of lesions per 10 kb in the nucleus of epimastigote from T. cruzi versus time in hours, after exposure to 1500 J m−2 of UVC. The
concentration of DNA lesions was measured up to 24 h after treatment, as above.
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diately after treatment. In the absence of RNAi the nuclear
signal was no longer detectable one and 24 h later, con-
sistent with the rapid repair indicated by the quantitative
PCR assay. In contrast, a pronounced nuclear signal for
cisplatin was seen in the TbCSB RNAi-induced cells one
and 24 h after exposure. Moreover, quantification of the
cisplatin signal in individual nuclei confirmed increased
persistence of cisplatin lesions in individual cells after RNAi
of TbCSB. These data indicate that cisplatin repair is
impeded by the loss of TbCSB.
Fig. 4. TbCSB, TbXPBz and TbXPG participate in TC-NER of lesions induced by cisplatin. Survival curves of TbXPC, TbDDB, TbCSB,
TbXPB, TbXPBz, TbXPD and TbXPD (A–G respectively) RNAi depleted cells (dotted lines) compared with respective uninduced controls
(solid lines) after exposure to 1, 2 or 5 μM cisplatin. Percent survival was calculated as the relative number of cells present in the treated
groups compared with untreated control. Values are means of three experiments, and vertical lines denote standard deviation.
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Fig. 5. Lesions generated by cisplatin are removed from trypanosomatid DNA with high efficiency.
A. Number of lesions per 10 kb in the nucleus of T. brucei bloodstream form cells versus time in hours after the treatment with 100 μM of
cisplatin for 1 h. The concentration of DNA lesions was measured up to 10 h after the treatment. Each value is the mean of two biological
replicates, and were derived from relative quantitative PCR amplification values obtained from two independent measurements.
B. Number of lesions per 10 kb in the nucleus of T. cruzi epimastigote forms versus time in hours, after the treatment with 300 μM cisplatin for
1 h. The concentration of DNA lesions was measured up to 24 h after the treatment, as above.
C. Immunofluorescence microscopy of cisplatin lesions (cisplatin adducts) in BSF T. brucei cells one hour after exposure to 50 μM cisplatin,
with (+ RNAi) or without (− RNAi) prior induction of RNAi against TbCSB for 48 h (0 h; inserts provide a focus on individual cells to show the
predominantly nuclear cisplatin signal relative to the DAPI stained and phase contrast images). Below are images of the RNAi induced or
uninduced cells, 1 and 24 h after exposure to cisplatin.
D. Quantification of cisplatin immunofluorescence relative to DAPI in individual TbCSB RNAi-induced cells (dotted line) and uninduced controls
(solid line) 0, 1 and 24 h after exposure to 50 μM cisplatin. Values are mean pixels ratios (Alexa/DAPI), measured from all parasite nuclei
present in ten different fields of each cell and at each time point; bars depict standard deviation, and * and *** indicate P-values of < 0.05 and
< 0.001 respectively.
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Evaluation of mRNA levels following RNAi of NER
factors in T. brucei
To investigate the impact that RNAi against NER factors
has on transcription, mRNA levels of a number of genes
spanning an ∼ 170 kbp multigenic transcription unit (local-
ized around the region used in the assay of DNA repair
kinetics) were measured by qRT-PCR before and after
RNAi induction (Fig. 6). RNAi against four of the seven
putative NER genes had no strong effect on the abundance
Fig. 6. Evaluation of mRNA levels following RNAi of NER factors in T. brucei. (A) A region of Lister 427 T. brucei chromosome 8, spanning
nucleotides 860 000–1 072 999, is shown. Within this region a ∼ 170 kbp multigenic transcription unit spanning 63 genes (green boxed arrows)
is indicated (green arrow above the genes denotes the extent of transcription in a left to right direction in this region), as well as some genes
from adjacent transcription units (red arrows; transcription not shown). Direction of transcription and translation is indicated by the arrows, and
the size of the locus in shown (kb). mRNA levels were measured for seven genes, which are highlighted in dark green and labelled to reflect
gene nomenclature in http://tritrypdb.org: 2890 (Tb427.08.2890), 2940 (Tb427.08.2940), 3230 (Tb427.08.3230), 3310 (Tb427.08.3310), 3350
(Tb427.08.3350), 3490 (Tb427.08.3490) and 3520 (Tb427.08.3520). mRNA levels were compared by qRT-PCR in the absence or presence of
tetracyclin induction of RNAi against the putative NER factors TbXPC (B), TbXPB (C) or TbXPD (D). * and ** indicate P-values < 0.05 and
< 0.01 respectively. This figure is available in colour online at wileyonlinelibrary.com.
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of the transcripts examined (mRNA levels are shown in
Fig. 6B for TbXPC as an example; TbDDB, TbXPBz and
TbXPG, data not shown). The effect of TbCSB RNAi is
discussed below (Fig. 7). RNAi of TbXPB or TbXPD
caused a decrease in mRNA levels: RNAi of the former
significantly reduced mRNA levels for five of the seven
analysed genes, while RNAi of the later significantly
reduced mRNAlevels for three of the seven genes (Fig. 6C
and D). This most likely reflects the role of TbXPB and
TbXPD as constituents of the TbTFIIH complex in vivo, and
is consistent with TbXPD contributing to SL-RNAtranscrip-
tion (Lee et al., 2009).
Evaluation of mRNA levels following TbCSB RNAi and
after DNA damage
To assess the role of TbCSB in transcription after DNA
damage, mRNA levels of genes in the polycistron were
next measured following RNAi of TbCSB and exposure
to UV irradiation or cisplatin (Fig. 7). In the absence of
DNA damage RNAi of TbCSB reduced the mRNA abun-
dance of three of the four genes most distal from the
transcription start (3230, 3310, 3350). Treatment with
UV, in the absence of TbCSB RNAi, caused the same
effect in these three transcripts, and additionally led to
small increases in mRNA levels of the two genes most
proximal to the transcription start (within ∼ 10 kbp; 2890
and 2940). Taken together, these data show that UV
damage or TbCSB RNAi affects mRNA abundance, but
in complex ways, possibly dependent on location within
a polycistron. When TbCSB was depleted by RNAi and
the cells were exposed to UV, mRNA levels increased
significantly for five of the seven genes analysed when
compared with the untreated and uninduced control. In
addition, increased mRNA levels were seen for all genes
relative to the TbCSB RNAi-induced, non-UV treated
and to the non-RNAi-induced, UV-irradiated cells. All
these effects were most pronounced for the three genes
most proximal (∼ 2, 10 and 60 kbp) to the transcription
start site (Fig. 7A). These data suggest that loss of
TbCSB increases the generation or stability of mRNAs
in the presence of UV damage.
Distinct effects to those seen with UV were observed
after exposure to cisplatin (Fig. 7B). As was seen follow-
ing UV, mRNA levels of the two genes most proximal to
the promoter (2890 and 2940) increased after TbCSB
RNAi induction and drug exposure relative to all other
conditions, and again the mRNA levels for genes 3230,
3310, 3350 reduced after TbCSB RNAi or cisplatin expo-
sure. However, unlike after UV treatment, mRNAs from
the five genes situated further downstream in the polycis-
tron decreased after TbCSB RNAi and cisplatin exposure
relative to the levels seen in the uninduced and untreated
control (Fig. 7B). These data suggest that TbCSB medi-
ates a different NER response to damage induced by UV
or cisplatin, which may be consistent with the differing
repair kinetics of damage caused by the two treatments
(Figs 3 and 5) and the different growth response of
T. brucei cells following exposure to the two forms of
damage and after RNAi against TbXPG (Figs 2 and 4).
Fig. 7. Evaluation of mRNA levels following TbCSB RNAi and
after DNA damage. The mRNA levels of genes 2890, 2940, 3150
(T7.08.3150), 3230, 3310, 3350 and 3520 (see Fig. 6) are shown in
RNAi-induced cells, with and without DNA damage, compared with
non-induced controls. Statistical analyses comparing only the RNAi
plus DNA damage groups (grey bars) against respective controls
(white, black and cross-hatched bars) are represented: *, **, ***
and **** indicate P-values of < 0.05, < 0.01, < 0.001 and < 0.0001
respectively.
A. DNA damage induced by 1500 J m−2 UVC.
B. DNA damage induced after exposure to 50 μM cisplatin for 3 h.
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Predicted GG-NER proteins in T. brucei are involved in
inter-strand cross-link repair
Cyclophosphamide is an alkylating agent that adds mono-
functional adducts at the N7 position of guanine and leads
to the formation of DNA inter-strand cross-links (ICLs)
involving two guanines (Povirk and Shuker, 1994). It has
been used as a chemotherapeutic agent in a set of cancers
and autoimmune diseases (Dollery, 1999). ICLs are pro-
cessed in eukaryotes by the cooperation of three DNA
repair and/or bypass pathways: NER, homologous recom-
bination and translesion synthesis (McVey, 2010). To
investigate the role of the predicted T. brucei NER genes
during ICL repair, the BSF RNAi cell lines were cultivated in
the presence of different doses of cyclophosphamide and
survival measured before and after RNAi induction (Fig. 8).
RNAi against TbXPC and TbDDB resulted in increased
sensitivity to cyclophosphamide, indicating that these
genes could be important in ICL repair. In contrast, RNAi
depletion of TbCSB, TbXPBz, TbXPG, TbXPD or TbXPB
had no effect on cyclophosphamide sensitivity. These data
suggest that the separation of function we observed
between the predicted GG-NER and TC-NER proteins in
T. brucei’s response to UV or cisplatin is mirrored in the
response to the cyclophosphamide: though TbXPC and
TbDDB act in ICL repair, TbCSB, TbXPBz and TbXPG do
not. Furthermore, these data add to the UV and cisplatin
survival curves to provide more evidence that TbXPB or
TbXPD do not act in DNA repair.
Discussion
Much of the genome of trypanosomatids appears to be
transcribed continuously, since most genes are arranged in
multigene units, each transcribed from a single promoter
(Vanhamme and Pays, 1995; Siegel et al., 2009; 2011).
This unusual mode of gene expression prompted us to
investigate how NER operates, and in this study we have
presented a near comprehensive functional analysis of the
predicted machinery of NER in T. brucei. Our findings
suggest that NER in T. brucei, and therefore most likely in
related trypanosomatids, has undergone extensive func-
tional diversification relative to other eukaryotes. Despite
conservation of most predicted NER proteins, our data
indicate that only TbCSB, TbXPBz and TbXPG contribute
to UV and/or cisplatin repair, suggesting that TC-NER
predominates. TbXPC and TbDDB, which would be
expected to mediate GG-NER, show no evidence for a role
in UV or cisplatin repair. Despite this, RNAi indicates that
these factors are essential and act in ICL repair, suggesting
that the GG-NER subpathway acts predominantly in an
unknown but critical process in trypanosomatid genome
maintenance. Finally, TbXPB and TbXPD show no evi-
dence for a role in repair of any lesions tested, suggesting
that T. brucei NER does not involve the TFIIH complex.
Taken as a whole, this work suggests that genome main-
tenance by NER in this parasite may be quite unlike that of
most eukaryotes: contrary to the expectation that the
TC-NER and GG-NER subpathways should act in parallel
and feed into a common lesion excision pathway, it
appears that T. brucei has evolved a profound focus on
TC-NER and has largely or completely uncoupled the
GG-NER factors and TFIIH from this reaction.
Does NER in T. brucei utilize a simplified machinery
compared with other eukaryotes?
The analytical work reported here and elsewhere (see
below) suggests that predictions of NER conservation in
T. brucei based on homology masks a streamlining of the
machinery devoted to NER, as well as neofunctionaliza-
tion. A major element of NER streamlining is non-
engagement of the TFIIH complex during the reaction,
which appears to be associated with the evolution of a
repair-specific XPB-related helicase, TbXPBz (or TbXPBr;
Badjatia et al., 2013). Here we show that loss of TbXPBz by
RNAi does not affect T. brucei viability, but that such RNAi
renders BSF T. brucei cells sensitive to UV and cisplatin
damage, showing that TbXPBz acts in DNA repair. In
contrast, RNAi of TbXPB or TbXPD was lethal, but we
found no evidence that loss of either helicase increased
sensitivity to DNA damage. These findings are consistent
with other studies. Lecordier et al. (2007) reported very
similar rates of cell death following RNAi of TbXPB or
TbXPD in procyclic form (PCF) and BSF cells, and Badjatia
et al. (2013) have demonstrated that null mutants of
TbXPBz can be generated in PCF T. brucei and display the
same increased sensitivity to UV and cisplatin as TbXPBz
RNAi-induced BSF cells (this study). Thus, the distinct
functions of the related helicases TbXPBz and TbXPB
appear to be retained throughout the parasite life cycle.
Moreover, though TbXPB and TbXPD act in concert as
components of the T. brucei TFIIH complex and are impor-
tant in transcription (Lecordier et al., 2007), there is no
evidence that TbXPBz associates with the TFIIH complex
or contributes to transcription (Lee et al., 2009; Badjatia
et al., 2013).
TbXPBz orthologues in trypanosomatids retain all con-
served domains related to DNA helicase function
(Lecordier et al., 2007; Badjatia et al., 2013), suggesting
that XPB duplication arose to provide helicase-related
activities for DNA repair that replace, or assume greater
importance than, TbXPB-TFIIH. Though it has been pro-
posed from sequence alignments that TbXPBz is capable
of interacting with TbXPC and thus mediating GG-NER
(Badjatia et al., 2013), the lack of evidence for TbXPC (or
TbDDB) involvement in NER appears inconsistent with
this (see below). In contrast, the phenotypes of TbXPBz
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Fig. 8. Predicted GG-NER proteins in T. brucei are involved in inter-strand cross-link repair. Survival curves of TbXPC, TbDDB, TbCSB,
TbXPB, TbXPBz, TbXPD and TbXPD (A–G respectively) RNAi depleted cells (dotted lines) compared with respective uninduced controls
(solid lines), after treatment with 2.5, 5 or 10 mM cyclophosphamide. Percent survival was calculated as the relative number of cells present in
the treated groups compared with the untreated control. Values are means of three experiments, and vertical lines denote standard deviation.
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RNAi strongly phenocopy those of TbCSB RNAi, suggest-
ing that TbXPBz predominantly acts together with TbCSB
in TC-NER. Whether or not this aspect of NER speciali-
zation is specific to kinetoplastids, or is also found in the
wider range of protists that possess two XPBs (Badjatia
et al., 2013), is unknown. Moreover, what aspects of
TbXPBz prevent its recruitment into TFIIH and favours its
association with TbCSB are unknown. Indeed, how
TC-NER in T. brucei might operate without engaging
TFIIH is unclear. In other eukaryotes, XPB is a weak
helicase and ablation of this activity does not impede
NER, while loss of XPD helicase is detrimental to NER
(Coin et al., 2007), suggesting that XPD plays the greater
role in extrusion of the lesion strand. Given these obser-
vations, the question of whether TbXPBz associates with
another helicase in a functionally distinct variant of the
TFIIH complex, lacking TbXPB and TbXPD, or acts in an
unrelated complex, merits further investigation. In this
light, the observations that TbXPBz interacts with Tbp52
(Badjatia et al., 2013), and that RNAi of Tbp52 or Tbp44
results in MMS and/or UV light sensitivity (Lecordier et al.,
2007; Badjatia et al., 2013), are intriguing. One interpre-
tation of these data is that at least some components of
trypanosomatid TFIIH act in the DNA damage response,
perhaps consistent with remodelling to incorporate
TbXPBz and exclude TbXPB and TbXPD. However,
sequence analysis of TbXPG provides further evidence
that T. brucei NER has evolved to act without TFIIH.
We have shown that RNAi of TbXPG leads to increased
sensitivity to cisplatin, indicating a role in TC-NER that
would be consistent with work in other eukaryotes, where
XPG has been shown to interact with CSB and play an
early role in this NER subpathway (Iyer et al., 1996;
Sarker et al., 2005). However, the polypeptide sequence
of TbXPG displays notable sequence losses in the central
spacer region relative to XPG orthologues (Fig. S7). Since
the spacer region mediates the interaction of XPG with
TFIIH (Dunand-Sauthier et al., 2005), mutations in this
part of parasite protein suggest that engagement of
TbXPG during NER is achieved without TFIIH. Indeed,
lack of T. brucei TFIIH function in NER may underlie the
potential absence of an identifiable trypanosmatid XPA
orthologue, whose role appears to be in stabilizing TFIIH
association with the NER machinery (Krasikova et al.,
2010). Superficially, this putative bypass of TFIIH appears
reminiscent of archaea, where XPB can interact with
Bax1, a functional equivalent of the XPG nuclease (Rouil-
lon and White, 2011). However, direct interaction between
TbXPBz and TbXPG has not been observed, and a static
complex appears incompatible with the differing response
to UV exposure following RNAi against the two factors in
T. brucei (discussed below). In addition, whether or not
further endonucleases, such as XPF/ERCC1, contribute
to NER in T. brucei awaits further investigation.
Is translesion RNA synthesis an important alterative to
TC-NER in T. brucei?
A number of observations lead us to propose that
T. brucei may not always respond to transcription-
blocking lesions by executing TC-NER. First, RNAi
against TbCSB and TbXPBz resulted in increased sensi-
tivity to both UV and cisplatin, whereas RNAi against
TbXPG only caused increased sensitivity to cisplatin, not
UV. Second, measuring repair kinetics shows that UV
lesions are repaired substantially more slowly than cispla-
tin lesions in trypanosomes, and that TbCSB is needed to
repair the latter type of damage. Finally, analysis of a
number of genes spanning a T. brucei multigene tran-
scription unit indicates differing changes in mRNA abun-
dance following exposure to UV or cisplatin and after
RNAi against TbCSB: increased mRNA levels were seen
for promoter-distal genes after UV exposure, but reduced
levels for the same genes after cisplatin. We suggest that
these observations are most simply explained by RNA Pol
II bypass of some lesions in some circumstances, and
that CSB plays a pivotal role in the decision to invoke such
a bypass or to enact TC-NER (Lee et al., 2002). Transle-
sion synthesis by any RNA Pol has not been documented
in trypanosomatids, but is well established in other
eukaryotes. Lesions occurring in transcribed DNA strands
lead to RNA Pol II blockage or slowdown, increasing CSB
affinity with TFIIH, a recruitment that mediates the prefer-
ential repair of lesions localized in transcribed strands
through TC-NER (Hanawalt and Spivak, 2008). Alterna-
tively, DNA lesions present in the template strand can be
bypassed by RNA Pol II (Saxowsky and Doetsch, 2006;
Bregeon and Doetsch, 2011). CPDs can be bypassed
during transcription because RNA Pol II has the ability to
incorporate A residues in front a CPD dimer: the first A is
incorporated in a non-template fashion, following the
‘A-rule’, while the second is inserted in a template-
directed manner. When one U is incorporated instead of
the second A, this mismatch induces RNA Pol II stalling.
Thus, at least in S. cerevisae, the complete translesion
transcription process through CPDs can be error-free
(Brueckner et al., 2007; Walmacq et al., 2012). Though
more work is needed, we suggest that the choice between
translesion RNA synthesis and TC-NER is able to explain
all the data we present.
We suggest that UV damage in T. brucei can be
bypassed by translesion synthesis or removed by NER,
and that TbCSB is pivotal in detecting such lesions and
channelling them to TC-NER only if needed. Bypass of
such lesions may normally be favoured due to multigenic
transcription, avoiding accumulation of stalled RNA Pol II
and promoting continued movement of the transcription
machinery. In fact, this may be the reason that TFIIH is
uncoupled from T. brucei NER, thus limiting CSB’s ability
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to engage NER. A preference for UV lesion bypass would
explain why we see little evidence for rapid repair of UV
damage. When TbCSB is removed, this control point is
lost and TC-NER cannot occur, meaning that bypass pre-
dominates further and explaining why mRNA levels
increased after TbCSB RNAi. It is likely that lesion bypass
is a short-term response to minimal damage, and might
explain the increased survival we observed in T. brucei
BSF TbCSB RNAi-induced cells within the first four hours
after UV exposure (Fig. S10). However, if bypass tran-
scription is error-prone, it could lead to an overproduction
of mutated mRNAs that could be toxic for the parasite,
explaining the increased sensitivity in TbCSB RNAi cells
24 h after UV irradiation. We further suggest that cisplatin-
induced adducts have a more pronounced effect on
T. brucei transcription than UV, inducing RNA Pol II block-
ages that cannot be as efficiently bypassed (Damsma
et al., 2007). Thus, the primary response to cisplatin, and
perhaps other platinum compounds, is that TbCSB
signals for lesion removal by enacting TC-NER and
engaging TbXPG. This model explains why TbXPG RNAi
cells are more sensitive to cisplain, but not UV, and why
cisplatin is seen to be rapidly removed in the repair assay.
The model also explains why cisplatin treatment results in
decreased mRNA levels of most genes in the polycistron
after TbCSB RNAi: here, TC-NER is impaired and cispla-
tin adducts cause increasing transcription impairment
through polycistons.
Why is loss of some predicted T. brucei NER
factors lethal?
We have argued above that NER in T. brucei is largely
conducted by a simplified TC-NER pathway, involving
TbCSB, TBXPBz and TbXPG. In this light, the data that we
present on the functions provided by the predicted
T. brucei GG-NER factors are remarkable, since RNAi of
TbXPC or TbDDB results in cell death, at least in the BSF.
The essentiality of TbXPB and TbXPD has been docu-
mented before in T. brucei (Lecordier et al., 2007) and is
explained by these factors’ roles as components of the
TFIIH complex; hence, their removal impedes transcrip-
tion, as seen by reduced mRNA levels following RNAi (this
study) and evaluated by in vitro transcription assays
(Badjatia et al., 2013). In contrast, why the GG-NER
factors are essential is less clear. In S. cerevisiae, null
mutants of RAD4 (XPC), RAD23, RAD1 (XPF) and RAD10
(ERCC1) have been documented and are viable (Giaever
et al., 2002). Phenotypes of NER mutation appear more
severe in multicellular eukaryotes but, even here, at least
some NER components appear to be dispensable. In
A. thaliana XPF/ERCC1 null mutants are viable (Vannier
et al., 2009), while in mice substantial gene deletions of
XPC are viable (Sands et al., 1995) and a near complete
null of ERCC1 does not prevent embryo growth until after
gestation. In C. elegans, loss of RAD23 or XPC is not
immediately lethal, with the former ablation allowing com-
plete embryonic development but maternal sterility
(Kamath et al., 2003). The essentiality of TbDDB and
TbXPC in T. brucei appears not to be due to critical contri-
butions to NER, since we find no evidence that TbDDB or
TbXPC repair UV or cisplatin damage. However, this DNA
damage may have the most pronounced effect in the highly
transcribed core of the T. brucei genome, and we cannot
yet discount that GG-NER is important in the subtelom-
eres, which harbour thousands of VSG genes and are
largely transcriptionally silent (Berriman et al., 2005;
Marcello and Barry, 2007). Nonetheless, we have provided
preliminary evidence that GG-NER may have assumed a
predominant role in non-NER DNA repair.
The lack of recognition of UV-induced lesions by TbXPC
and TbDDB is remarkable, since UV-induced lesions are
recognized by XPC and XPE during GG-NER in most
studied organisms (Feldberg and Grossman, 1976; Chu
and Chang, 1988). Rad4, the S. cerevisiae homologue of
XPC, recognizes (together with RAD23) ssDNA structures
associated with bulky lesions. To do this, a β-hairpin
domain of Rad4 is inserted through the DNA double helix,
evicting the damaged strand away from its binding site.
This mechanism of XPC DNA damage recognition
accounts for the remarkable range of bulky lesions tar-
geted by GG-NER (Min and Pavletich, 2007). To ask if the
lack of UV damage repair by GG-NER may be accounted
for by alterations in TbXPC, the three dimensional structure
of the parasite protein was modelled on the structure of
Rad4 protein bound to DNA (Fig. 9). By measuring the
distance between the ‘arms’ that form the lesion recogni-
tion site in the two proteins, we calculated the approximate
size of the DNAbinding site to be around 13 Å for Rad4 and
around 27 Å for TbXPC. Since the diameter of a DNA
double helix is approximately 20 Å, it is plausible to infer
that Rad4 can only recognize one DNA strand, while
TbXPC may bind both strands. This modelling raises the
possibility that TbXPC can bind both damaged and undam-
aged DNA strands, and might explain why GG-NER in
trypanosomes is not targeted to DNA damage caused by
UV and cisplatin. This putative alteration in TbXPC DNA
binding may also be related to the more pronounced role
we see for the T. brucei GG-NER proteins acting in ICL
repair, based on the observation that RNAi of TbXPC or
TbDDB caused sensitivity to the ICL inducer cyclophos-
phamide.
ICLs are highly genotoxic DNA lesions whose repair
requires several factors derived from a number of inde-
pendent DNA repair pathways (McVey, 2010). A role for
GG-NER proteins in ICL repair has been seen in S. cerevi-
siae (Saffran et al., 2004), where rad4Δ mutants (XPC
mutants) shows sensitivity to the ICL-causing agents
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mechlorethamine, mitomycin C and cisplatin (McHugh
et al., 1999; Wu et al., 2004). However, mammal cells
deficient for XPA or XPC present only moderate sensitivity
to ICL-inductors (Clingen et al., 2007). High sensitivity to
ICL-inducing agents, as well as bone marrow failure and
high cancer frequencies, are observed in humans harbour-
ing mutations in Fanconi Anemia core complex genes
(Deans and West, 2011), which appear to be missing in
lower eukaryotes. Thus, in single-celled eukaryotes like
yeast and trypanosomatids ICL recognition and repair by
GG-NER proteins may assume greater importance.
However, if ICL repair is the main role of the GG-NER
pathway in T. brucei, it remains unclear why this activity
should assume such great importance. From the molecular
modelling above, we infer a novel mechanism employed by
TbXPC for DNA lesion binding relative to Rad4 (Min and
Pavletich, 2007). However, it is unclear if this novelty is due
to greater commitment of the T. brucei GG-NER system to
ICL recognition, since Rad4 can act in ICL repair and,
indeed, the human XPC-Rad23b complex also binds to a
psoralen ICLs (Thoma et al., 2005). Further investigation
will be necessary to address the lesion spectrum targeted
by TbXPC and, until then, it remains unclear what essential
purpose these GG-NER factors provide. Nonetheless, the
possibility that TbXPC and TbDDB, previously thought to
act in NER, might have assumed a distinct and essential
genome maintenance role is interesting. If it can be shown
that GG-NER provides an activity distinct from the host,
this repair pathway might represent a target for therapeutic
intervention against Sleeping Sickness and other trypano-
somatid diseases.
Experimental procedures
Parasite growth
Epimastigote forms of Trypanosoma cruzi CL Brener strain
were cultivated at 28°C in LIT (Liver Infusion Tryptose)
medium (pH 7.3; Camargo, 1964) supplemented with 10%
heat-inactivated fetal bovine serum (FBS, Cultilab) plus
100 U ml−1 penicillin and 100 μg ml−1 streptomycin (Invitro-
Fig. 9. TbXPC presents a larger DNA damage recognition site when compared with its yeast homologue. Left: a comparison of the structure
of Rad4 (green) and the predicted structure of TbXPC (purple); secondary structures are shown, overlapped with the surface, and the
distance difference between the ‘arms’, which constitutes the DNA lesion recognition site, of both proteins is depicted. Right: Surface
representation of the structure of Rad4 (green) and the predicted structure of TbXPC (purple), bound to a double-stranded DNA molecule.
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gen). Bloodstream form Trypanosoma brucei were cultivated
at 37°C in a humidified incubator with 5% CO2. Parasites
were grown in HMI-9 (Hirumi and Hirumi, 1989) supple-
mented with 20% heat-inactivated FBS (Sigma) plus 1% (v/v)
of penicillin and streptomycin (Sigma).
Growth after RNAi in the presence and absence of
genotoxic agents
To measure growth, the parasites were diluted to a density of
1 × 105 cells ml−1 in HMI-9 plus selective drugs (hygromycin
and phleomycin), with and without tetracycline (1 μg ml−1, to
induce RNAi). Cell cultures were diluted 10-fold daily and cell
numbers counted in a heamocytometer chamber at 24 h inter-
vals; each growth curve was carried out three times indepen-
dently for each RNAi cell line. To evaluate sensitivity to DNA
damage, the cells were similarly diluted to 1 × 105 cells ml−1,
and tetracycline added as before. After 24 h the cells were
exposed to the genotoxic agents, and the cell growth allowed
to proceed as before. Survival rate was calculated from the cell
counts of the drug-exposed cells relative to the untreated
controls. All survival curves were performed in triplicate. For
the cisplatin survival curve, parasites were treated with 1, 2 or
5 μM of cisplatin (Sigma). In the UV irradiation survival curve,
parasites received doses of 500, 1500 or 3000 J m−2 of UVC
using a Stratalinker® UV Crosslinker (Stratagene). For cyclo-
phosphamide (Sigma) exposure, parasites were grown in
concentrations of 2.5, 5 and 10 mM.
RNAi
The primers utilized for RNAi constructs were designed using
software available online (http://trypanofan.path.cam.ac.uk/
software/RNAit.html); in each case Attb1 and Attb2 recombi-
nation sites were added to the termini of the primers. The
sequences of the primers used to PCR-amplify the RNAi
cassettes are on Table S1. All primers were purchased from
Eurofins MWG Operon (http://www.eurofinsdna.com). The
Attb1 and Attb2 sites allowed Gateway recombination in a
single reaction, inserting two copies of the product in opposing
directions into the pGL2084 vector to generate a stem-loop
RNAi producing construct (Jones et al., 2014). For PCR, a
master mix was used: 1× Phusion Buffer, 0.2 mM dNTP mix,
50 ng of template genomic DNA from Lister 427 T. brucei,
2 μM of each primer and 20 u ml−1 of Phusion enzyme (Invit-
rogen). The PCR reactions were carried out with settings of
3 min at 98°C, 30 cycles of 98°C for 30 s, 60°C for 30 s and
72°C for 30 s, and a final step for 10 min at 72°C. PCR
products were purified from 1% agarose gels using the Qiagen
MinElute Kit and used in RNAi construct assembly into
pGL2084. For the assembly reaction ≥ 10 ng of PCR product,
150 ng of pGL2084 vector, 0.25 μl of BP Clonase™ enzyme
mix (Invitrogen), Tris-HCl 3.75 mM and EDTA375 μM (pH 8.0)
were used. The mix reaction was incubated at room tempera-
ture for 1 h. To transform Max efficiency DH5α E. coli (Invitro-
gen Cat. No. 18258-012), 1 μl of BP clonase reaction was
used, as described by the manufacturer. The clones obtained
for each reaction were grown in LB medium supplemented
with ampicilin at 100 μg ml−1 at 37°C overnight and the RNAi
constructs were then isolated using Qiagen QIAprep Spin Kit.
To test if the extracted plasmids were successfully recom-
bined, double digestions with BamHI and XbaI, and single
digestions with StuI or ClaI, were performed. Next, the RNAi
constructs were linearized by digestion with AscI and 5 μg of
linearized plasmid were used to transfect BSF T. brucei 2T1
cells (Alsford and Horn, 2008). For transfection 1 × 107 cells
were harvested by centrifugation for 10 min for 1500 g. After
media was removed, cells were resuspended in 100 μl of
Amaxa Nucleofector T-cell buffer, transferred to a cuvette and
10 μl of the linearized DNA were added. Electroporation was
performed using the program X-001 on the Nucleofector II
machine. Cells were then transferred to 30 ml of HMI-9
medium without selective drugs. After 6 h, the cells were
diluted at 1:20 and 1:40 in media containing selective drugs:
hygromycin (2.5 μg ml−1) and phleomycin (0.5 μg ml−1). Antibi-
otic resistant clones were selected for at least 7 days. In order
to test if the RNAi cassette had been correctly integrated, the
parasites’ sensitivity to puromycin (1.0 μg ml−1) was tested.
Real-time PCR
To validate the RNAi, levels of target mRNAs for each gene
were measured by quantitative reverse transcriptase PCR
(qRT-PCR). A total of 2 × 107 cells were harvested from RNAi-
induced and uninduced cultures at the times stated, and total
RNA was isolated using the Qiagen RNeasy Kit (with
on-column DNaseI digestion). For all qRT-PCRs a master mix
for 30 reactions was made in which each reaction had 12.5 μl
of SYBR Green PCR Master Mix (Applied Biosystems), 1.0 μl
of each primer (300 nM stock), 9.5 μl of dH2O, and 1.0 μl
cDNA (generated by SuperScript First-Strand Synthesis
System for RT-PCR (Invitrogen) from the total RNA, accord-
ing to manufacturer’s instructions). Reactions were run on an
ABI Prism 7000 thermocycler and mRNA levels quantified
from the amplifications according to the manufacturer’s
instructions; conditions for all reactions were 50°C for 2 min,
95°C for 10 min, followed by 40 cycles of 95°C for 15 s and
60°C for 1 min. Primers recognizing GPI8 (CTOL27 and
CTOL28) were used as a control (Tiengwe et al., 2012).
Primer pairs for each putative NER gene are provided on
Table S1. The mRNA levels from the polycistron genes were
also assessed by qRT-PCR (for primers details, see Table
S1), using the same procedures. All primers were purchased
from Eurofins MWG Operon. All qRT-PCR experiments were
performed at least three times independently. Statistical
analysis was performed using unpaired t-test for compari-
sons of mRNA levels between RNAi cell lines and uninduced
controls. An ordinary one-way ANOVA followed by Tukey’s test
was performed to compare mRNA levels after 24–48 h of
RNAi induction, while a two-way ANOVA followed by Tukey’s
test was performed to compare mRNA levels after RNAi
induction in the presence of DNA damage. All statistical
analysis was conducted using the software GraphPad Prism.
Comparative modelling and docking
A TbXPC molecular structure was generated by comparative
modelling. The search for candidate template structures was
performed by BLAST searches of the PDB database
(Westbrook et al., 2003). The template used for modelling was
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Rad4 2QSH chain A (S. cerevisiae XPC homologue; Min and
Pavletich, 2007). The TbXPC molecular model was built based
only on the β-hairpin domains of Rad4, corresponding to
positions 400–700 of the full-length protein. Sequence align-
ments between TbXPC and its structural template were gen-
erated by Promals 3D (Pei et al., 2008) and manually curated.
Molecular modelling was performed using the program Mod-
eller (version 9.7; Eswar et al., 2007), which generated a
hundred possible structures. The validation of obtained
models according to stereochemical quality was performed
through the analysis of Ramachadran plots generated by the
program Procheck (version 3.5.4; Morris et al., 1992) and the
energetic characteristics were assessed using ProSA (ProSa
2003; Wiederstein and Sippl, 2007). Perl scripts were
designed and used to automatically retrieve the percentage of
residues in the most favoured regions of the Ramachandran
plot and the Z-score of ProSA for each one of the 100 struc-
tures. Three different types of software were used to determine
potential protein-DNAbinding sites: DNABindR, BindN (and its
variant BindNPlus) and DBSPSSM (Ahmad and Sarai, 2005;
Wang and Brown, 2006; Yan et al., 2006). Results were clus-
tered and all amino acids predicted as DNA-binding by at least
one of the three algorithms were considered as active residues
during docking experiments. Docking calculations were
carried out in Haddock (Dominguez et al., 2003) advanced
guru interface, defining active residues in the proteins as
described above, and defining passive residues as all resi-
dues within a radius of 6 angstroms around the active resi-
dues. For the DNAmolecules, all nucleotides were considered
as active residues in protein-DNA interaction. All additional
parameters were used as default values. The generated com-
plexes were analysed through stereochemical, cluster-sizes
and energy evaluations.
Immunofluorescence
Approximately 1 × 106 cells were collected, washed once in
PBS, and allowed to attach for 4 min to 12-well multi-well
glass slides (Thermo Scientific) that had been previously
coated with Poly-L-lysine (Sigma Aldrich). The cells were
then fixed with 4% formaldehyde in PBS for 15 min, washed
twice with PBS, incubated with 0.5% Triton X-100 for 20 min,
and further washed with PBS (twice). Next, the cells were
incubated for 30 min with 2 M HCL, washed 5 times with
PBS, and then blocked with 20% heat-inactivated FBS
(Sigma-Aldrich) for 30 min at 37°C, after which the wells were
washed 5 times with PBS. Primary antisera were used
according to the manufacturer instructions: mouse anti-(6-4)
phosphoproducts (6-4 PPs) antibody (Cosmo Bio Co., Ltd) at
a 1:300 dilution, mouse anti-cyclobutane pyrimidine dimers
(CPDs) antibody (Cosmo Bio Co., Ltd) at a 1:1500 dilution,
and mouse anti-cisplatin antibody (Abcam) at a 1:400 dilu-
tion. In all cases, the antiserum was added to the cells in PBS
containing 5% FBS, and incubated for 30 min at 37°C. The
cells were then washed 5 times with PBS, and further incu-
bated for 30 min at 37°C with Alexa Fluor 594 goat anti-
mouse IgG (H+L) (Invitrogen) antibody at a dilution of 1:100
in PBS containing 5% FBS. The wells were then washed 5
times with PBS and the slides mounted in VECTASHIELD
mounting medium with DAPI (1.5 μg ml−1) (Vector Laborato-
ries). The slides were examined, and images acquired, using
an Axioskop 2 fluorescence microscope (Zeiss). Images were
processed and assembled in Adobe Photoshop (Adobe
Systems). A two-way ANOVA followed by a Bonferroni post-
test was performed to compare the levels of cisplatin-induced
damage in experimental repeats comparing TbCSB RNAi
induced cells and uninduced controls. Statistical analysis was
conducted using the software GraphPad Prism.
DNA lesion detection through quantitative PCR
To detect the level of DNA damage in the nuclear genome, a
quantitative PCR-based technique was used according to
previously described protocols (Santos et al., 2006). Briefly,
lesion frequency was assessed through relative PCR-
amplification of a 10 kb fragment of the T. brucei or T. cruzi
genome, comparing amplification after treatment with geno-
toxic agents relative to untreated controls. A small, internal
DNA fragment, comprising 204 and 250 bp (in T. brucei an
T. cruzi respectively) was PCR-amplified from the 3′ extremity
of the larger molecule in order to correct for DNAloading errors
or PCR bias and assure that amplification conditions were the
same for all samples. For DNA damage induction in T. brucei,
approximately 1 × 108 BSF cells of strain Lister 427 were
harvested by centrifugation for 15 min at 3000 g at 4°C and
resuspended in the same volume of 1× PBS. Next, cells were
exposed to 100 μM cisplatin for 1 h. For UVC exposure,
1 × 108 parasites were concentrated in 5 ml of media. The cells
were then spread in a small Petri plate and exposed to
1500 J m−2 of UVC in a Stratalinker® UV Crosslinker (Strata-
gene). For DNA damage induction in T. cruzi, 1 × 108 epimas-
tigote form cells, CL Brener strain, were used. Parasites were
centrifuged as for T. brucei and treated with 300 μM of cisplatin
in 1× PBS for 1 h. For UV treatment, 5 ml of culture containing
1 × 108 T. cruzi cells were spread in a small Petri plate and
irradiated with 1500 J m−2 of UVC. In all cases, the cells were
centrifuged after treatment (as before) and resuspended in
conditioned medium, i.e. the medium used in the original
culture. Untreated samples were processed in the same way.
Samples were collected at appropriate time points subsequent
to the above treatments (0, 1, 2, 5 and 10 h after treatment for
T. brucei, and 0, 1, 5 and 24 h for T. cruzi), centrifuged at 3000
g and 4°C for 15 min, and the resulting cell pellet immediately
frozen at −80°C. DNA was prepared from the cells using the
Blood & Cell Culture DNA Mini Kit (QIAGEN), according to the
manufacturer’s instructions for DNA extraction from tissues.
DNA was then quantified using PicoGreen dye (Molecular
Probes) and standard curves, as described by Santos et al.
(2006). PCR was performed from 15 ng of template DNAusing
the GeneAmp XL PCR Kit (Applied Biosystems) and the
resulting amounts of PCR product quantified, again using
PicoGreen and as described by Santos et al. (2006). The
primers used in the amplification reaction of the large fragment
in T. brucei were qPCRFoward (5′-GTTGCTCACTTTCACC
ACGTATTCGGGAACCTGT-3′) and qPCRReverse (5′-CCA
CTGAATGCTGTATCCGGCATTTAGTCGTGTCTATGGG-3′);
for T. cruzi the large fragment used the primers QPCRNuc2F
(5′-GCACACGGCTGCGAGTGACCATTCAACTTT-3′) and
QPCRNuc2R (5′-CCTCGCACATTTCTACCTTGTCCTTCAA
TGCCTGC-3′). To PCR-amplify the small fragment, used as
the internal control, the primers qPCRFI (5′-TTACAGCAC
CCAGGTTTATACCGCACGAAAGTGG-3′) and qPCRRe-
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verse were used in T. brucei, while the primers QPCRNuc2Int
(5′-TCGAGCAAGCTGACACTCGATGCAACCAAAG-3′) and
QPCRNuc2R were used in T. cruzi. PCR reactions must to be
carried out only until the logarithmic phase, when the amplifi-
cation yields are directly proportional to the starting amount of
template. To meet these requirements, PCR conditions in this
experiment need to optimized for each lab, as they are
dependent on many factors, including the type of PCR
machine used and the accuracy of genomic DNA template
quantification using the PicoGreen dye system (see Santos
et al., 2006 for guidelines and for the quantification strategy).
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